Quince Therapeutics (QNCX) Earnings Date & Reports

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

QNCX is expected to report earnings to fall 32.14% to -18 cents per share on May 13

Quince Therapeutics QNCX Stock Earnings Reports

Q1'25

Est.

$-0.19

Q4'24

Missed

by $0.10

Q3'24

Missed

by $0.03

Q1'23

Missed

by $0.03

Q4'22

Beat

by $0.14

The last earnings report on March 24 showed earnings per share of -28 cents, missing the estimate of -17 cents. With 81.50K shares outstanding, the current market capitalization sits at 58.08M.

View a ticker or compare two or three

Compare

QNCX